Clinical Trials Directory

Trials / Completed

CompletedNCT04015167

A Post-Market Clinical Evaluation of the Treatment of Tibia Fractures With the T2 Alpha Tibia Nailing System

Status
Completed
Phase
Study type
Observational
Enrollment
103 (actual)
Sponsor
Stryker Trauma and Extremities · Industry
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

This investigation is a prospective, multi-center clinical investigation. It is anticipated that a total of 80 subjects will be enrolled. Neither subjects nor investigators are blinded to treatment and the clinical investigation includes a historical control which will be compared to the T2 Alpha Tibia Nailing System. Total duration of enrollment, 12 month follow-up and analysis is expected to take 31 months. The clinical investigation has been designed to follow the surgeon's standard of care for tibia fractured subjects, in addition to a 12 month follow-up visit. The primary endpoint of this clinical investigation is to confirm efficacy/performance at 12 months, as measured by the SF-36 Physical Component Summary (PCS). Confirmation of efficacy/performance at 12 months will be based on an equal or higher (non-inferior) SF-36 Physical Component Summary (PCS) result of the T2 Alpha Tibia Nailing System compared to the benchmark literature.

Detailed description

The objective of this clinical investigation is to demonstrate the safety and efficacy/performance of the T2 Alpha Tibia Nailing System. Efficacy/performance of the procedure will be measured by an equal or higher (non-inferior) SF-36 Physical Component Summary (PCS) score result of the T2 Alpha Tibia Nailing System compared to the T2 Tibia benchmark literature at 12 months. In addition, demonstration of bone consolidation in correct alignment will be measured by Investigator assessment by 12 months. Safety of the T2 Alpha Tibia Nailing System will be demonstrated through reporting of device related intra-operative and post-operative Adverse Events/incidents by 12 months.

Conditions

Interventions

TypeNameDescription
DEVICET2 Alpha Tibia Nailing SystemThe T2 Alpha Tibia Nailing System is intended for temporary stabilization of bone segments or fragments until bone consolidation has been achieved.

Timeline

Start date
2019-09-12
Primary completion
2022-11-10
Completion
2023-08-08
First posted
2019-07-10
Last updated
2025-01-06
Results posted
2025-01-06

Locations

4 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04015167. Inclusion in this directory is not an endorsement.